Clinical Trial Update: A Phase II Study of Anlotinib in STS Patients [Phase 2]

View source ↗

Summary

Phase II study update of Anlotinib in cancer patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Cancer | Phase 2 | Status: COMPLETED